LE LUMEÇON
Board
1 director, last change in 2024Director (not named in the articles), permanent representative ISSOM Bruno
appointed by deed of 16-02-2024
term without a fixed end
earlier manager, until 16-02-2024
listed in the 2025 annual accounts, filed on 22-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 16-02-2024
Permanent representatives 1
Mandates through the years
1 name, the dashed line is todayDISSEMA PHARMA
Director (not named in the articles)
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
- DISSEMA PHARMA
- Director (not named in the articles), since before 31-12-2021
- Manager, until 16-02-2024
Control
Parent
Equity €293,207
Profit €26,259 in 2025 (profit €23,033 in 2024)
Source: accounts Dissema Pharma 2025
100%
This company
LE LUMEÇON
Equity €110,578
Profit €44,603 in 2025
Capital
- Contribution
- €6,200
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- Dissema Pharma
Source: lists of holdings in the owners' accounts
Articles of association
deed of 16-02-2024 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Friday of June at 17:00